PRNewsWire
16 Nov 2026, 21:43 UTC · 3h ago
Candel Therapeutics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Candel Therapeutics (CADL)
Impact · against what's priced in
The market has already reacted to Candel's BLA delay and new ATM program, but the initiation of a legal investigation into disclosure violations introduces new litigation risk. Ionis and Ingredion are not materially affected by the core news of this article.
- IONS+0.00
Doesn't touch the price's assumptions
- The price assumes
The company's stated goal of exceeding $5 billion in 2030 revenue





